IPO registrations (S-1, F-1) · Registrants

Aditxt, Inc.

SEC CIK
1726711 · filings on EDGAR ↗
Former names
ADiTx Therapeutics, Inc. (2020–2021); Aditx Therapeutics, Inc. (2020–2021)
Registration
Form S-1, first filed 2020-01-15, last 2025-06-20; 9 initial registrations, 16 amendments
Outcome
Final prospectus filed 2020-07-01; declared effective 2020-06-29; withdrawal requested 2023-09-22
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
737 N. FIFTH STREET, SUITE 200, Richmond, VA 23219
EIN
82-3204328
EDGAR entity type
operating
Insiders and CEO pay
Aditxt, Inc. on the corporate pages

Offering terms

Final price
$9.00 per share (424B4 filed 2020-07-01, an initial public offering)
Shares sold
1,226,668
Gross proceeds
$11,040,012 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ADTX
Lead underwriters
Dawson James (472,222 shares)
Syndicate
James Securities, Inc; ViewTrade (377,223); Securities, Inc; The Benchmark Company (377,223)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 42

FiledFormWhat it isName as filedEDGAR
2020-01-15S-1S-1 (registration)ADiTx Therapeutics, Inc.0001213900-20-001135 ↗
2020-02-07S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-002914 ↗
2020-02-19S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-004282 ↗
2020-04-28S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-010308 ↗
2020-05-14S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-012077 ↗
2020-05-29S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-013734 ↗
2020-06-17S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-015193 ↗
2020-06-24S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-015613 ↗
2020-06-25S-1/AS-1/A (amendment)ADiTx Therapeutics, Inc.0001213900-20-015750 ↗
2020-06-29EFFECTEFFECT (declared effective)ADiTx Therapeutics, Inc.9999999995-20-001668 ↗
2020-07-01424B4424B4 (final prospectus)ADiTx Therapeutics, Inc.0001213900-20-016472 ↗
2020-08-28S-1S-1 (registration)ADiTx Therapeutics, Inc.0001213900-20-024322 ↗
2020-09-01EFFECTEFFECT (declared effective)ADiTx Therapeutics, Inc.9999999995-20-002338 ↗
2020-09-02S-1MEFS-1MEF (added securities)ADiTx Therapeutics, Inc.0001213900-20-024908 ↗
2020-09-03424B4424B4 (final prospectus)ADiTx Therapeutics, Inc.0001213900-20-025234 ↗
2021-02-04S-1S-1 (registration)Aditx Therapeutics, Inc.0001213900-21-006626 ↗
2021-02-10EFFECTEFFECT (declared effective)Aditx Therapeutics, Inc.9999999995-21-000565 ↗
2021-07-13EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-21-002744 ↗
2022-07-18S-1S-1 (registration)Aditxt, Inc.0001213900-22-039769 ↗
2022-09-15S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-22-056026 ↗
2022-09-15S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-22-056228 ↗
2022-09-16S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-22-056371 ↗
2022-09-16EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-22-002729 ↗
2022-09-20424B4424B4 (final prospectus)Aditxt, Inc.0001213900-22-057179 ↗
2023-06-29S-1S-1 (registration)Aditxt, Inc.0001213900-23-052531 ↗
2023-09-15S-1S-1 (registration)Aditxt, Inc.0001213900-23-077044 ↗
2023-09-21EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-23-002719 ↗
2023-09-22RWRW (withdrawal request)Aditxt, Inc.0001213900-23-078579 ↗
2023-11-07S-1S-1 (registration)Aditxt, Inc.0001213900-23-084402 ↗
2023-11-13EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-23-003339 ↗
2024-01-18S-1S-1 (registration)Aditxt, Inc.0001213900-24-004519 ↗
2024-01-26S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-24-007068 ↗
2024-02-14S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-24-013683 ↗
2024-05-14S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-24-042539 ↗
2024-06-05S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-24-050059 ↗
2024-06-13EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-24-001830 ↗
2024-08-06EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-24-002435 ↗
2024-09-11S-1/AS-1/A (amendment)Aditxt, Inc.0001213900-24-077771 ↗
2024-09-13EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-24-002845 ↗
2025-06-20S-1S-1 (registration)Aditxt, Inc.0001213900-25-056288 ↗
2025-06-30EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-25-002100 ↗
2026-04-21EFFECTEFFECT (declared effective)Aditxt, Inc.9999999995-26-001275 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2020-06-25S-1/Aregistration statement$9.001,333,334$12,000,006Nasdaq ADTX1primary document; price sentence, shares headline, proceeds computed, underwriting table 1, cover names 1document ↗
2020-07-01424B4final prospectus$9.001,226,668$11,040,012Nasdaq ADTX5primary document; price sentence, shares headline, proceeds table, underwriting table 3, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Albanna Amro A.Director,Officer; OfficerChief Executive Officer; CHIEF EXECUTIVE OFFICER82020–2023
ANTHONY LAURA EDirector42020–2021
Brady Brian MichaelDirector62020–2025
Pankovcin CorinneOfficerCCO; CHIEF FINANCIAL OFFICER; Chief M&A Officer72020–2025
Shabahang ShahrokhDirector,Officer; OfficerChief Innovation Officer; CHIEF INNOVATION OFFICER82020–2023
Kiaie NamvarDirector52020–2021
Albanna RowenaOfficerChief Operating Officer; CHIEF OPERATING OFFICER82020–2023
McLeod Rosland FisherDirector12020
Runge Jeffrey W.Director72020–2023
Farley Thomas JOfficerChief Financial Officer; PRINCIPAL ACCOUNTING OFFICER42021–2023
Chung LaurenDirector22021
Shatzkes MatthewOfficerChief Legal Officer and GC12022
BNP PARIBAS SECURITIES CORPOther; TenPercentOwner22023
Nelson Charles AthleDirector22023
HRT FINANCIAL LPTenPercentOwner152024–2026
PELLETIER SAUNDRA LDirector12025
Hermina SylviaDirector12025
Porcelli Christopher JonOfficerGeneral Counsel, CPO & CS12025
Gong SandieTenPercentOwner22026
Xu Devon XinTenPercentOwner22026
BANK OF AMERICA CORP /DE/TenPercentOwner22026
BANK OF AMERICA NATenPercentOwner22026
BOFA SECURITIES, INC.TenPercentOwner22026
DRW Securities, LLCTenPercentOwner22026
Takeover Time 2026 LLCTenPercentOwner22026
Tai Wey AnnTenPercentOwner22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2024-01-23Aditxt, Inc.Biotechnology$6,000,000$6,000,00011
2023-09-20Aditxt, Inc.Biotechnology$10,000,000$10,000,00011
2022-08-17Aditxt, Inc.Biotechnology$2,200,000$2,033,33361
2021-01-26Aditx Therapeutics, Inc.Biotechnology$6,000,000$6,000,00011
2018-12-26ADiTx Therapeutics, Inc.Biotechnology$2,000,000$109,80041
2018-03-29ADiTx Therapeutics, Inc.Biotechnology$2,000,000$262,50081

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerAditxt, Inc.VAForm D private offeringsCIK (EXACT)
SEC filerAditxt, Inc.SEC filers (EDGAR)CIK (EXACT)
Business registrationAditxt, Inc.State business registriesname and state
Lobbying clientADITXT INC.Federal lobbying (LDA)name and state

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, VA first:

More with this interest.

In other datasets, the same topic (Health) in VA:

Interests: Pharmaceutical Preparations · Health